| |
|
| |
 |
| |
|
| |
|
North America
|
|
A comprehensive assessment of new product introductions in the U.S. nonprescription drugs industry over the past ten years, including new ingredients, new technologies, new indications/claims, "ease of use" improvements, and innovative product...
|
| |
|
North America
|
|
This comprehensive annual survey is considered the authoritative source of information on the nonprescription drugs industry. It contains sales data on hundreds of OTC brands and companies, new product and ad spending analysis, retail distribution...
|
| |
|
North America
|
|
Impact of Recessions on the U.S. OTC Market is a comprehensive assessment that will provide subscribers with a historical perspective on industry performance during recessions over the past three decades in order to estimate impacts of the current...
|
| |
|
North America
|
|
The third report in Kline & Company’s OTC Perceptual Research series, focusing on retailers’ perceptions of 10 leading OTC marketers in the U.S. food, drug, mass merchandiser, and alternative retail channels. The study will be based on more than...
|
| |
|
North America
|
|
Active delivery systems, also known as targeted drug delivery systems, have introduced innovative ways to deliver actives in prescription pharmaceuticals for some time now. The shift from a “mass delivery” protocol to “optimized delivery”...
|
| |
|
North America
|
|
This study is designed to provide OTC marketers with a comprehensive look at how and why consumers buy OTC drugs. It will examine their unmet needs to provide subscribers with insights and actionable recommendations on which they can base new...
|
| |
|
North America
|
|
This study provides an in-depth analysis of Canada's nonprescription drug industry, including 25 product categories and profiles of 15 major and 20 minor over-the-counter drug manufacturers. The report provides information on sales and market share...
|
| |
| |
|
| |
|
| |
|
North America
|
|
This comprehensive report provides subscribers with objective, independent forecasts of future Rx-to-OTC switches and their expected impacts on the OTC market. This analysis will provide forecasts of future switches in existing OTC categories and...
|
| |
|
| |
